#TRLInsights - 42% of clinical trial terminations across 2022 occurred in phase 2 studies.

14 Aug 2023, 11:01
#TRLInsights - 42% of clinical trial terminations across 2022 occurred in phase 2 studies. The most prominent reasons for termination were business/strategic decisions and low accrual rates. Source: #blockchainforhealth #TRL

Same news in other sources

2
Triall
TriallTRL #2216
Telegram
14 Aug 2023, 11:02
Triall Insights šŸ” 42% of clinical trial terminations across 2022 occurred in phase 2 studies. The most prominent reasons for termination were business/strategic decisions and low accrual rates. Source: globaldata.com/store/report/clinical-trial-investigations-ranking-analysis/ āš”ļø Trade $TRL at bit.ly/tradeTRL šŸ—£ Help us spread the news on Twitter: #blockchainforhealth #TRL
Triall Insights. 42% of clinical trial terminations across 2022 occurred in phase 2 studies.
Triall Insights šŸ” 42% of clinical trial terminations across 2022 occurred in phase 2 studies. The most prominent reasons for termination were business/strategic decisions and low accrual rates. Source: globaldata.com/store/report/clinical-trial-investigations-ranking-analysis/ āš”ļø Trade $TRL at bit.ly/tradeTRL šŸ—£ Help us spread the news on Twitter: https://twitter.com/triallofficial/status/1691042341010690049?s=20 #blockchainforhealth #TRL
Triall
TriallTRL #2216
Telegram
14 Aug 2023, 11:02
Triall Insights šŸ” 42% of clinical trial terminations across 2022 occurred in phase 2 studies. The most prominent reasons for termination were business/strategic decisions and low accrual rates. Source: globaldata.com/store/report/clinical-trial-investigations-ranking-analysis/ āš”ļø Trade $TRL at bit.ly/tradeTRL šŸ—£ Help us spread the news on Twitter: #blockchainforhealth #TRL
Triall Insights. 42% of clinical trial terminations across 2022 occurred in phase 2 studies.
Triall Insights šŸ” 42% of clinical trial terminations across 2022 occurred in phase 2 studies. The most prominent reasons for termination were business/strategic decisions and low accrual rates. Source: globaldata.com/store/report/clinical-trial-investigations-ranking-analysis/ āš”ļø Trade $TRL at bit.ly/tradeTRL šŸ—£ Help us spread the news on Twitter: https://twitter.com/triallofficial/status/1691042341010690049?s=20 #blockchainforhealth #TRL